The increasing use of mass cytometry for analyzing clinical samples offers the possibility to perform comparative analyses across public datasets. However, challenges in batch normalization and data integration limit the comparison of datasets not intended to be analyzed together. Here, we present a data integration strategy, CytofIn, using generalized anchors to integrate mass cytometry datasets from the public domain. We show that low-variance controls, such as healthy samples and stable channels, are inherently homogeneous, robust against stimulation, and can serve as generalized anchors for batch correction. Single-cell quantification comparing mass cytometry data from 989 leukemia files pre- and post normalization with CytofIn demonstrates effective batch correction while recapitulating the gold-standard bead normalization. CytofIn integration of public cancer datasets enabled the comparison of immune features across histologies and treatments. We demonstrate the ability to integrate public datasets without necessitating identical control samples or bead standards for fast and robust analysis using CytofIn.
The drug discovery process from hit-to-lead has been a challenging task that requires simultaneously optimizing numerous factors from maximizing compound activity, efficacy to minimizing toxicity and adverse reactions. Recently, the advance of artificial intelligence technique enables drugs to be efficiently purposed in silico prior to chemical synthesis and experimental evaluation. In this chapter, we present fundamental concepts of artificial intelligence and their application in drug design and discovery. The emphasis will be on machine learning and deep learning, which demonstrated extensive utility in many branches of computer-aided drug discovery including de novo drug design, QSAR (Quantitative Structure–Activity Relationship) analysis, drug repurposing and chemical space visualization. We will demonstrate how artificial intelligence techniques can be leveraged for developing chemoinformatics pipelines and presented with real-world case studies and practical applications in drug design and discovery. Finally, we will discuss limitations and future direction to guide this rapidly evolving field.
28 September 2024 in Advances in Computational Intelligence
Amperometric biosensors are widely used in point-of-care medical devices that help patients control blood glucose and cholesterol levels in an effective and convenient way. On the other hand, computer-aided technologies for biosensor design remain an actively developing field. In this chapter, we present a computational model for biosensor design that uses a reaction-diffusion equation. We have successfully applied this model to simulate cholesterol analysis based on a multienzyme system. Furthermore, we show that this computer-aided approach can be used to optimize biosensor performance. This model can be applied to industry-grade biosensor development and can be easily extended to model multiple types of biosensors for a wide array of clinical applications.
Novel application of SEM comparison of walnut husk fly and the olive fruit fly. The samples were rendered, coated, then viewed in the scanning electron microscopes.